Xencor, Inc. (XNCR) earnings
XNCR earnings moved a median of -2.78% by the close. Quarterly and annual XNCR reports and results, each read against the price at its own news timestamp. Back to the XNCR overview →
26 measured XNCR earnings events.
Where these XNCR earnings landedvs 26 measured XNCR earnings reactions
| Middle 50% of XNCR earnings reactions | -4.98% to +1.37% |
|---|---|
| Median reaction (to close) | -2.78% |
| Measured reactions | 26 |
Point-in-time · zero look-ahead
Half of the 26 XNCR earnings events with a measured close landed between -4.98% and +1.37%; 35% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Xencor Inc For: Jun 30 | SEC filing · Form 10-Q | -2.50% | -8.93% | |
| Xencor Reports Second Quarter 2026 Financial Results | Press release | -2.50% | -8.93% | |
| Form 10-Q Xencor Inc For: Mar 31 | SEC filing · Form 10-Q | -1.34% | -2.61% | |
| Xencor Reports First Quarter 2026 Financial Results | Press release | -1.34% | -2.61% | |
| Form 10-K Xencor Inc For: Dec 31 | SEC filing · Form 10-K | -3.23% | +8.14% | |
| Form 10-Q Xencor Inc For: Sep 30 | SEC filing · Form 10-Q | +3.96% | -2.78% | |
| Xencor Reports Third Quarter 2025 Financial Results | Press release | +3.96% | -2.78% | |
| Form 10-Q Xencor Inc For: Jun 30 | SEC filing · Form 10-Q | +0.65% | -4.31% | |
| Xencor Reports Second Quarter 2025 Financial Results | Press release | +0.65% | -4.31% | |
| Form 10-Q Xencor Inc For: Mar 31 | SEC filing · Form 10-Q | +1.91% | +11.97% | |
| Xencor Reports First Quarter 2025 Financial Results | Press release | +1.91% | +11.97% | |
| Form 10-K Xencor Inc For: Dec 31 | SEC filing · Form 10-K | +1.28% | +1.15% | |
| Form 10-K/A Xencor Inc For: Dec 31 | SEC filing · Form 10-K | +0.06% | -4.98% | |
| Form 10-Q/A Xencor Inc For: Jun 30 | SEC filing · Form 10-Q | +0.06% | -4.98% | |
| Form 10-Q/A Xencor Inc For: Mar 31 | SEC filing · Form 10-Q | +0.06% | -4.98% | |
| Form 10-Q/A Xencor Inc For: Sep 30 | SEC filing · Form 10-Q | +0.06% | -4.98% | |
| Form 10-Q Xencor Inc For: Sep 30 | SEC filing · Form 10-Q | -1.53% | +1.44% | |
| Xencor Reports Third Quarter 2024 Financial Results | Press release | -1.53% | +1.44% | |
| Form 10-Q Xencor Inc For: Jun 30 | SEC filing · Form 10-Q | -0.80% | +1.71% | |
| Xencor Reports Second Quarter 2024 Financial Results | Press release | -0.80% | +1.71% | |
| Form 10-Q Xencor Inc For: Mar 31 | SEC filing · Form 10-Q | +2.12% | -4.71% | |
| Xencor Reports First Quarter 2024 Financial Results | Press release | +2.12% | -4.71% | |
| Form 10-K Xencor Inc For: Dec 31 | SEC filing · Form 10-K | -0.56% | -1.92% | |
| Form 10-Q Xencor Inc For: Sep 30 | SEC filing · Form 10-Q | -5.19% | -5.17% | |
| Xencor Reports Third Quarter 2023 Financial Results | Press release | -5.19% | -5.17% | |
| Xencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023 | Press release | -1.09% | +0.63% |
Keep exploring
More XNCR: analyst actions → · SEC filings → · XNCR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cellectis S.A. - American Depositary Shares (CLLS) | 285 | -0.01% | 37% |
| Prestige Consumer Healthcare Inc. (PBH) | 285 | -0.11% | 45% |
| NOVELION THERAPEUTICS INC COMMON SHARES (NVLN) | 283 | 0.00% | 42% |
| Tenax Therapeutics, Inc. (TENX) | 283 | -0.29% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.